United Therapeutics
UTHR
#1103
Rank
โ‚ฌ17.86 B
Marketcap
395,12ย โ‚ฌ
Share price
0.38%
Change (1 day)
10.51%
Change (1 year)

Revenue for United Therapeutics (UTHR)

Revenue in 2025 (TTM): โ‚ฌ2.80 Billion

According to United Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ2.63 Billion. In 2024 the company made a revenue of โ‚ฌ2.76 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ2.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for United Therapeutics from 1999 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ2.80 B1.27%
2024 โ‚ฌ2.76 B31.33%
2023 โ‚ฌ2.10 B16.64%
2022 โ‚ฌ1.80 B21.29%
2021 โ‚ฌ1.48 B23.41%
2020 โ‚ฌ1.20 B-6.75%
2019 โ‚ฌ1.29 B-9.11%
2018 โ‚ฌ1.42 B-1.04%
2017 โ‚ฌ1.43 B-5.4%
2016 โ‚ฌ1.51 B13.38%
2015 โ‚ฌ1.34 B26.53%
2014 โ‚ฌ1.05 B30.99%
2013 โ‚ฌ0.80 B16.79%
2012 โ‚ฌ0.69 B21.02%
2011 โ‚ฌ0.57 B27.15%
2010 โ‚ฌ0.45 B74.35%
2009 โ‚ฌ0.25 B28.2%
2008 โ‚ฌ0.20 B39.38%
2007 โ‚ฌ0.14 B19.42%
2006 โ‚ฌ0.12 B23.64%
2005 โ‚ฌ97.85 M80.37%
2004 โ‚ฌ54.24 M28.05%
2003 โ‚ฌ42.36 M47.04%
2002 โ‚ฌ28.81 M343.96%
2001 โ‚ฌ6.49 M198.35%
2000 โ‚ฌ2.17 M337.79%
1999 โ‚ฌ0.49 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚ฌ52.84 B 1,906.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ50.00 B 1,799.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ9.27 B 252.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ24.47 B 829.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
โ‚ฌ197.19 B 7,389.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ35.64 B 1,253.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
โ‚ฌ73.39 M-97.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.11 B 436.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel